Roku (ROKU) closed the most recent trading day at $223.95, moving +0.05% from the previous trading session. The stock lagged the S&P 500's daily gain of 0.88%. Meanwhile, the Dow gained 0.57%, and the Nasdaq, a tech-heavy index, added 1.39%.
Kroger (KR) closed the most recent trading day at $34.45, moving +0.47% from the previous trading session. This change lagged the S&P 500's 0.88% gain on the day. Meanwhile, the Dow gained 0.57%, and the Nasdaq, a tech-heavy index, added 1.39%.
In the latest trading session, Tractor Supply (TSCO) closed at $149.93, marking a +0.48% move from the previous day. The stock lagged the S&P 500's daily gain of 0.88%. Elsewhere, the Dow gained 0.57%, while the tech-heavy Nasdaq added 1.39%.
Alleghany Corporation Y is adversely impacted by higher catastrophic events, weak underwriting results and declines in interest income.Shares of this Zacks Rank #3 (Hold) property and casualty (P&C) insurer have lost 30.9% on a year-to-date basis compared with the industry
This week, Eli Lilly LLY has applied for the emergency use of its coronavirus antibody candidate and Pfizer PFE/BioNTech has started rolling filing for their COVID-19 vaccine approval in Europe. AstraZeneca AZN resumed its COVID-19 vaccine study in Japan.
Shares of Aflac Inc. AFL have exhibited a downtrend so far this year due to macroeconomic volatility, induced by the coronavirus as well as operational issues in its Japan business, which contributed nearly 70% to the company’s revenues in 2019.
Mastercard Inc. MA made an undisclosed investment in the fintech company named Marqeta, which instantly issues cards and processes card payments with its open Application Programming Interface (API) platform.
It is a well-documented fact that the transportation sector is one of the worst-affected corners of the investment world that bore a massive brunt of the coronavirus pandemic. The space, which includes airlines, railroads, truckers, shippers and package delivery companies to nam
Amgen Inc. AMGN along with partners Cytokinetics, Incorporated CYTK and Servier announced top-line data from the pivotal phase III GALACTIC-HF study, which is evaluating omecamtiv mecarbil, a novel cardiac myosin activator, developed for the treatment of heart failure with reduc
Investors seek growth stocks to capitalize on above-average growth in financials that help these securities grab the market's attention and produce exceptional returns. However, it isn't easy to find a great growth stock.
Investors seek growth stocks to capitalize on above-average growth in financials that help these securities grab the market's attention and produce exceptional returns. However, it isn't easy to find a great growth stock.
Growth stocks are attractive to many investors, as above-average financial growth helps these stocks easily grab the market's attention and produce exceptional returns. But finding a growth stock that can live up to its true potential can be a tough task.
Growth stocks are attractive to many investors, as above-average financial growth helps these stocks easily grab the market's attention and produce exceptional returns. But finding a great growth stock is not easy at all.
Growth stocks are attractive to many investors, as above-average financial growth helps these stocks easily grab the market's attention and produce exceptional returns. But finding a growth stock that can live up to its true potential can be a tough task.
Shares of Jazz Pharmaceuticals plc JAZZ were up 8% on Thursday after the company announced positive top-line data from a phase III study, which is evaluating its newly-approved drug Xywav for a new indication. The placebo-controlled withdrawal study is evaluating Xywav oral solu
HCA Healthcare, Inc. HCA recently announced preliminary results for the third quarter ended Sep 30, 2020.For the period, the company expected revenues to be $13.30 billion on a preliminary basis, indicating a 4.8% rise from the year-ago quarter’s reported figure.Notably, Incom
Shares of Regeneron Pharmaceuticals, Inc. REGN gained 1.38% after it submitted a request to the FDA for an Emergency Use Authorization (EUA) for its experimental COVID-19 treatment, REGN-COV2.
Wall Street expects a year-over-year decline in earnings on lower revenues when V.F. (VFC) reports results for the quarter ended September 2020. While this widely-known consensus outlook is important in gauging the company's earnings picture, a powerful factor that could impact
Broadridge Financial Solutions, Inc. BR yesterday announced that it has appointed Vijay Mayadas as president of Capital Markets, a newly created position. He will provide leadership to the company’s trading and post-trade capital markets’ Software-as-a-Service solutions as p